Molecular and Cellular Biology, April 2001, p. 2521-2532, Vol. 21, No. 7
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.7.2521-2532.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Department of Internal Medicine, Graduate School of Medicine, University of Tokyo, Tokyo 113-8655,1 Division of Laboratory Animal Science, Animal Research Center, Tokyo Medical University, Tokyo 160-8402,2 and Institute for Diabetes Care and Research, Asahi Life Foundation, Tokyo 100-0005,3 Japan
Received 10 July 2000/Returned for modification 30 August 2000/Accepted 20 December 2000
| |
ABSTRACT |
|---|
|
|
|---|
To investigate the role of insulin receptor substrate 1 (IRS-1) and
IRS-2, the two ubiquitously expressed IRS proteins, in adipocyte
differentiation, we established embryonic fibroblast cells with four
different genotypes, i.e., wild-type, IRS-1 deficient (IRS-1
/
), IRS-2 deficient (IRS-2
/
), and
IRS-1 IRS-2 double deficient (IRS-1
/
IRS-2
/
), from mouse embryos of the corresponding
genotypes. The abilities of IRS-1
/
cells and
IRS-2
/
cells to differentiate into adipocytes are
approximately 60 and 15%, respectively, lower than that of wild-type
cells, at day 8 after induction and, surprisingly,
IRS-1
/
IRS-2
/
cells have no ability to
differentiate into adipocytes. The expression of CCAAT/enhancer binding
protein
(C/EBP
) and peroxisome proliferator-activated receptor
(PPAR
) is severely decreased in IRS-1
/
IRS-2
/
cells at both the mRNA and the protein level,
and the mRNAs of lipoprotein lipase and adipocyte fatty acid binding
protein are severely decreased in IRS-1
/
IRS-2
/
cells. Phosphatidylinositol 3-kinase (PI
3-kinase) activity that increases during adipocyte differentiation is
almost completely abolished in IRS-1
/
IRS-2
/
cells. Treatment of wild-type cells with a PI
3-kinase inhibitor, LY294002, markedly decreases the expression of
C/EBP
and PPAR
, a result which is associated with a complete
block of adipocyte differentiation. Moreover, histologic analysis of
IRS-1
/
IRS-2
/
double-knockout mice
8 h after birth reveals severe reduction in white adipose tissue
mass. Our results suggest that IRS-1 and IRS-2 play a crucial role in
the upregulation of the C/EBP
and PPAR
expression and adipocyte differentiation.
| |
INTRODUCTION |
|---|
|
|
|---|
Recently there has been a dramatic increase in the prevalence of obesity attributable to excessive white adipose tissue both in Western countries and in Japan. Because adipocytes play a critical role in energy balance, understanding the molecular mechanisms of adipocyte differentiation may provide clues to strategies for the prevention and treatment of obesity.
The mechanisms of adipocyte differentiation have been extensively
studied in preadipocyte culture systems. Characterization of the
regulatory regions of adipose-specific genes has led to the
identification of key transcription factors in the complex transcriptional cascade that occurs during adipocyte differentiation (36); these factors include peroxisome
proliferator-activated receptor
(PPAR
) (19, 44),
CCAAT/enhancer binding protein (C/EBP) (12, 23, 32, 46, 52,
56), and adipocyte differentiation and determination factor 1 (ADD1)-sterol regulatory element binding protein 1c (SREBP1c)
(17, 18, 36, 45).
PPAR
is induced before the transcriptional activation of most
adipocyte-specific genes, and expression of PPAR
has been shown to
be sufficient to induce growth arrest and to initiate adipogenesis in
exponentially growing fibroblast cell lines, thus demonstrating its
critical role in the regulation of adipocyte differentiation (2,
15, 43). In addition, PPAR
-deficient cells fail to
differentiate into adipocytes, indicating that PPAR
plays a pivotal
role in adipocyte differentiation (21, 29). Most of the
PPAR
target genes in adipose tissue including the genes encoding
phosphoenolpyruvate carboxykinase (41), lipoprotein lipase
(LPL) (33) and adipocyte fatty acid binding protein
(A-FABP or aP2) (42) are directly implicated in lipogenic pathways.
C/EBP
is the most highly expressed member of C/EBP family in adipose
tissue and in liver and has been implicated in the maintenance of the
terminally differentiated adipocyte phenotype (4, 9, 25,
56). C/EBP
is induced relatively late during adipogenesis in
culture, after the induction of PPAR
but before the induction of
many of the enzymes and proteins characteristic of fully differentiated cells (53), and it transcriptionally activates a large
number of adipocyte-specific genes (8). C/EBP
-null mice
fail to develop white adipose tissue (48), and
C/EBP
-deficient cells fail to differentiate into adipocytes
(51). C/EBP
(1, 7, 9, 10, 56) and C/EBP
(4, 16, 49) are induced very early and have been shown to
play a crucial role in initiating the differentiation of preadipocytes
by activating the expression of PPAR
(39, 50, 52, 56).
An in vitro study of adipocyte differentiation in
C/EBP
/
C/EBP
/
embryonic
fibroblast (EF) cells shows that the expression of both PPAR
and
C/EBP
is severely reduced (39).
In addition, there is a large amount of literature describing extracellular factors that influence adipogenic potentials. These include insulin-like growth factor 1 (IGF-1) and insulin. However, little is known about the signal transduction pathways by which these hormones regulate the expression of these transcription factors and promote adipogenesis.
IRS-1 and IRS-2 are the two most ubiquitously expressed members of the IRS family of proteins, which can bind signaling proteins with Src-homology-2 domains (SH2 proteins), such as p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase), subsequent to the activation of receptors for insulin, IGF-1, and several cytokines (26, 28, 37). IRS-1 plays an important role in the metabolic actions of insulin and IGF-1 mainly in skeletal muscle and adipose tissue, and IRS-2 plays an important role in the metabolic actions of these hormones in the liver (3, 55). The roles of IRS-1 and IRS-2 in adipocyte differentiation, on the other hand, have not been reported.
To investigate the role of IRS-1 and IRS-2 in adipocyte
differentiation, we intercrossed mice heterozygous for each of two null
alleles (Irs1+/
[38] and
Irs2+/
[22]) and generated primary
EF cells that were wild type, IRS-1 deficient (IRS-1
/
),
IRS-2 deficient (IRS-2
/
), or IRS-1 IRS-2 double
deficient (IRS-1
/
IRS-2
/
).
We show here that IRS-1 IRS-2 double-deficient cells have no ability to
differentiate into adipocytes. We also show that the simultaneous lack
of both IRS-1 and IRS-2 dramatically decreases the expression of
C/EBP
and PPAR
at both the mRNA and the protein levels during
adipocyte differentiation. Thus, our data provide the first direct
evidence for the essential role of IRS-1 and IRS-2 in the expression of
adipose-specific transcriptional factors, such as the C/EBP family and
PPAR
, and adipocyte differentiation.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Materials.
The probe for Northern blot and RNase protection
assay to 36B4 was a generous gift from Naoya Yahagi (University of
Tokyo) (34). The polyclonal antibodies to IRS-1,
phosphotyrosine, PPAR
, and C/EBP
were from Santa Cruz
Biotechnology, Inc. Polyclonal antibodies to phospho-mitogen-activated
protein kinase (MAPK) and MAPK were from New England Biolabs, Inc. The
medium and penicillin-streptomycin solution were purchased from Gibco,
Inc. Fetal bovine serum (FBS) was from JRH Biosciences. The
nitrocellulose paper used for the immunoblots was from Schleicher & Schuell, Inc. The 3-isobutyl-1-methylxanthine (IBMX) and human
recombinant insulin were purchased from Sigma Chemical Co.
Dexamethasone (DEX) was purchased from Wako Pure Chemical Industries,
Ltd. L-type Wako TG-H (S-R1 and S-R2) for triglyceride measurement was
purchased from Wako Pure Chemical Industries, Ltd. BCA Protein Assay
Reagent (Pierce) was used for the protein assay.
Preparation of wild-type, IRS-1
/
,
IRS-2
/
, and IRS-1
/
IRS-2
/
EFs.
The IRS-1 IRS-2 double-heterozygous
mice (IRS-1+/
IRS-2+/
mice) were generated
by intercrosses of IRS-1-deficient mice (38) and
IRS-2-deficient mice (22). To obtain embryos at 13.5 days past coitus, conceptuses that were obtained by fertilization in vitro
of ova from IRS-1+/
IRS-2+/
female mice
with sperm from IRS-1+/
IRS-2+/
male mice
were implanted into pseudopregnant foster mothers, as previously
described (21). The foster mothers were sacrificed at 13.5 days past coitus, the embryos were dissected from the uterus, and the
extra-embryonic membranes and viscera were removed. The embryos were
cut into small pieces with scissors and soaked for 30 min in 4 ml of
0.25% trypsin-EDTA at room temperature with shaking, and then
inactivated with
-modified Eagle medium (
MEM) supplemented with
10% heat-inactivated FBS, 50 U of penicillin per ml, and 50 µg of
streptomycin per ml. The cells were then suspended by pipetting and
were plated on two 10-cm dishes per embryo. After 48 h, adherent
cells were trypsinized, counted, and replated at a density of 1.2 × 105 cells/cm2 in
MEM with 10%
heat-inactivated FBS, 50 U of penicillin per ml, and 50 µg of
streptomycin per ml to induce adipocyte differentiation.
Induction of adipocyte differentiation. The passage number of the EF cells used in these studies was within two passages. Induction of adipocyte differentiation was performed as previously described (39). In brief, cells were cultured on 24- or 6-well or 10-cm plastic dishes and propagated to confluence. Two days later, the medium was replaced with standard differentiation induction medium containing 0.5 mM IBMX, 1 µM DEX, 5 µg of insulin per ml, 10% FBS, 50 U of penicillin per ml, and 50 µg of streptomycin per ml, and the medium was renewed every other day.
Oil-Red O staining and triglyceride-protein assay. Oil-Red O staining solution (0.5% Oil-Red O in isopropyl alcohol solution-distilled water [60:40]) was filtered through the Whatman no. 1 filter paper and, after the cells were washed with phosphate-buffered saline (PBS), they were stained with the filtered staining solution for 30 min at 37°C and then washed with distilled water three times.
For the triglyceride-protein assay, the cells were washed with PBS twice, 0.8 ml of homogenizing buffer (150 mM sodium chloride, 10 mM Tris-HCl [pH 8.0], 0.1% Triton X-100) was added to each well of a 24-well plate, and the adherent cells were homogenized with Polytron. The homogenate was filtered with Samprep (0.2 µm [pore size]; Millipore), and the concentration of triglyceride in the filtered homogenate was measured by using L-type Wako TG-H (S-R1 and S-R2), and a triolein diluted with the homogenizing buffer was used as the standard. A 125-µl volume of the homogenate, 50 µl of S-R1, and 25 µl of S-R2 were used. The protein concentration of the same homogenate solution was measured with a bicinchoninic acid (BCA) assay kit.Retrovirus-mediated gene transfer.
To rescue adipocyte
differentiation of EF cells from IRS1
/
IRS2
/
, the PPAR
2 expression vector for
retrovirus-mediated gene transfer was constructed by ligating the
BstXI fragment from the pBabe-mPPAR
2-puro (kindly
provided by Bruce M. Spiegelman) into the BstXI site of pMX-puro (27). Mouse EF cells were infected with equal
titers of each recombinant virus as described previously
(44), with some modification.
PI 3-kinase assay. PI 3-kinase activity in EF cells was determined in immunoprecipitates with antibodies to phosphotyrosine as described previously (55), with some modification. In brief, EF cells were lysed with lysis buffer (0.25 M sucrose; 5 mM EDTA; 5 mM EGTA; 20 mM Tris-HCl, pH 7.4; 0.2 mM Na3VO4; 10 mM NaF; 10 mM sodium PPi, 1 mM phenylmethylsulfonyl fluoride; 10 µg of leupeptin per ml; 10 µg of aprotinin per ml) containing 1% NP-40. The lysates were cleared by centrifugation at 12,000 rpm in a microcentrifuge at 4°C, and the protein content of the supernatant was determined. Then, 50 µg of the cellular protein was subjected to immunoprecipitation with monoclonal antiphosphotyrosine antibody (PY20; Santa Cruz) by using protein G-Sepharose, and the buffer was changed to PI 3-kinase assay buffer (100 mM sodium chloride; 25 mM Tris-HCl, pH 7.4; 0.5 mM EGTA). The PI 3-kinase activity was then measured as described previously (55).
RNA preparation, Northern blot analysis and RNase protection assay. Total RNA was prepared from EF cells with Trizol (Gibco-BRL) according to the manufacturer's instructions.
Northern blot analysis was performed by a standard protocol. A 6-µg sample of total RNA was electrophoresed through denaturing formaldehyde-agarose (1%) gel and then transferred to a Hybond N+ nylon membrane (Amersham). cRNA probes for C/EBP
,
C/EBP
, C/EBP
, PPAR
, LPL, and 36B4 were labeled by in vitro
transcription with Strip-EZ RNA (Ambion) and [
-32P]UTP
(NEN Life Science Products, Boston, Mass.). The cDNA probe for aP2 was
labeled by random priming with the Megaprime DNA Labeling System
(Amersham) and [
-32P]dCTP (NEN Life Science Products).
A probe for SREBP1c that does not detect SREBP1a was designed and
constructed as described previously (35).
The RNase protection assay to measure SREBP1c mRNA and PPAR
was
performed with RPA III (Ambion). A 10-µg sample of total RNA was
hybridized with the cRNA probe, which was prepared with MAXIscript
(Ambion) and [
-32P]UTP (NEN Life Science Products).
Immunoblot analysis. EF cells were lysed in a lysis buffer containing 1% NP-40, and insoluble materials were removed by centrifugation. Proteins in the supernatants were assayed with a BCA protein assay kit (Pierce) and then subjected to immunoblotting analysis.
The tyrosine-phosphorylated proteins associated with PI 3-kinase were analyzed by immunoprecipitating equal amounts of protein (100 µg) with anti-PI 3-kinase p85 rabbit antiserum (anti-p85PAN; Upstate 06-195) and immunoblot analysis with the antiphosphotyrosine, PY20-horseradish peroxidase (HRP) conjugate antibody, or 4G10-HRP conjugate antibody. MAPK and phospho-MAPK were analyzed by electrophoresing 10 µg of protein from the cell lysates via sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on a 10% polyacrylamide gel and immunoblotting with PhosphoPlus p44/p42 MAPK (Thr202-Tyr204) Antibody Kit (New England Biolabs, Inc.) according to the manufacturer's instructions. PPAR
and C/EBP
were analyzed by electrophoresing 6 µg of
protein from the cell lysates by SDS-PAGE on a 12% polyacrylamide gel,
followed by immunoblotting with PPAR
(H-100) rabbit polyclonal immunoglobulin G (IgG) (1:500) and C/EBP
(14AA) rabbit polyclonal IgG (1:500).
Histologic analysis.
To generate IRS-1
/
IRS-2
/
mice, conceptuses that were obtained by in vitro
fertilization of ova from IRS-1+/
IRS-2+/
female mice and sperm from IRS-1
/
IRS-2+/
male mice were implanted into pseudopregnant foster mothers, as
previously described (21). At 8 h after birth,
neonates were fixed in 10% formaldehyde in PBS. Genomic DNA was
prepared from the tail of each neonate, and the genotype was determined
by PCR analysis. Neonate was cut into 10-µm sections, and the
sections were mounted on silanized slides. The adipose tissue was
stained with hematoxylin and eosin. All sections were examined by light microscopy.
| |
RESULTS |
|---|
|
|
|---|
Adipocyte differentiation of IRS-1
/
cells is
impaired.
Wild-type and IRS-1
/
cells were induced
to differentiation into adipocytes. Oil-Red O staining was performed 8 days after induction of adipocyte differentiation (Fig.
1A), and the increase in intracellular triglyceride content was measured (Fig. 1B). The ability of
IRS-1
/
cells to differentiate into adipocytes was found
to be approximately 60% lower than that of wild-type cells. These
results were reproduced in six independent IRS-1
/
cells
with six independent wild-type cells as controls.
|
PI 3-kinase activation during adipocyte differentiation in
IRS-1
/
cells was decreased.
PI 3-kinase activities
during adipocyte differentiation were measured in immunoprecipitates
with antibody to phosphotyrosine from lysates of wild-type cells and
IRS-1
/
cells (Fig. 2A).
PI 3-kinase activity increased during adipocyte differentiation and
reached a maximum at 8 days after induction, a result consistent with
observations in adipocyte cell lines 3T3-L1 and 3T3-F442A
(31). The increase in PI 3-kinase activity of in
IRS-1
/
cells during adipocyte differentiation was
approximately 50% less than that in the wild-type cells from 0 to 8 days after induction.
|
/
cells to differentiate into adipocytes.
LY294002 (20 µM) was shown to completely block adipocyte
differentiation of both wild-type and IRS-1
/
cells
(Fig. 2B), strongly suggesting that PI 3-kinase activity was required
for adipocyte differentiation.
We next studied the tyrosine-phosphorylated proteins associated with
the p85 subunit of PI 3-kinase during adipocyte differentiation and
found that a 170-kDa protein in wild-type cells, but a 180-kDa protein
in IRS-1
/
cells, was the major tyrosine phosphorylated
protein associated with the p85 subunit of PI 3-kinase (Fig. 2C). The
170-kDa protein was confirmed to be IRS-1 because this protein was
detected with anti-IRS-1 antobody in wild-type cells and was not
detected in IRS-1
/
cells (Fig. 2D). The 180-kDa protein
was strongly suggested to be IRS-2, because this protein had a
molecular mass 10 kDa larger than IRS-1 and was detected with
antiphosphotyrosine antibody in IRS-1
/
cells, but not
in IRS-2
/
cells or IRS-1
/
IRS-2
/
cells (Fig. 3A).
|
/
cells to
differentiate into adipocytes, we then investigated the ability of
IRS-2
/
cells and IRS-1
/
IRS-2
/
cells to differentiate into adipocytes.
PI 3-kinase and MAPK activities during adipocyte differentiation in
wild-type, IRS-1
/
, IRS-2
/
, and
IRS-1
/
IRS-2
/
cells.
We performed
immunoblotting analysis to identify the tyrosine-phosphorylated
proteins associated with the p85 subunit of PI 3-kinase during
adipocyte differentiation (Fig. 3A). At day 0 after induction,
tyrosine-phosphorylated 170-kDa proteins, which were recognized by
anti-IRS-1 antibody (data not shown), were weakly detected in wild-type
and IRS-2
/
cells (Fig. 3A; lanes 1 and 3). At 8 days
after induction, tyrosine phosphorylation of IRS-1 associated with PI
3-kinase in wild-type and IRS-2
/
cells was markedly
increased (Fig. 3A, lanes 5 and 7). In IRS-1
/
cells,
tyrosine phosphorylation of the 180-kDa protein associated with the p85
subunit of PI 3-kinase was induced (Fig. 3A, lane 6). This protein was
shown to be IRS-2 because it was not detected in IRS-2
/
cells and IRS-1
/
IRS-2
/
cells (Fig. 3A,
lanes 7 and 8). In IRS-1
/
IRS-2
/
cells,
tyrosine-phosphorylated proteins associated with the p85 subunit of PI
3-kinase were not detected in the 170- to 180-kDa range (Fig. 3A, lane 8).
/
cells had 50%
less PI 3-kinase activity than the wild-type cells, whereas the PI
3-kinase activity of IRS-2
/
cells was similar to
that of wild-type cells. As we predicted, the increase in PI
3-kinase activity during adipocyte differentiation was largely
abolished in IRS-1
/
IRS-2
/
cells. These
findings indicated that a major portion of PI 3-kinase activity which
increased during adipocyte differentiation was associated with IRS-1
and IRS-2.
A second important pathway activated through IRS-1 and IRS-2 is the
MAPK cascade. The amount and phosphorylation of MAPK protein was very
similar among the cells of each of the four genotypes and remained
constant during adipocyte differentiation (Fig. 3C).
IRS-1
/
IRS-2
/
cells failed to
differentiate into adipocytes.
The EF cells with each of the four
genotypes were induced to differentiation into adipocytes. Oil-Red O
staining was performed 8 days after induction to adipocyte
differentiation (Fig. 4A). The ability of
IRS-1
/
cells to differentiate into adipocytes was again
approximately 60% lower than that of wild-type cells. The ability of
IRS-2
/
cells to differentiate into adipocytes was
approximately 15% lower than that of wild-type cells (Fig. 4B).
Surprisingly, IRS-1
/
IRS-2
/
cells were
completely unable to differentiate into adipocytes (Fig. 4).
|
Expression of transcriptional factors for adipocyte differentiation
and adipogenic markers.
To identify the molecular mechanism for
the defective adipocyte differentiation in IRS-1
/
IRS-2
/
cells, we performed Northern blot analysis to
investigate gene expression of transcriptional factors for adipocyte
differentiation and adipogenic markers (Fig.
5A). The levels of C/EBP
expression in
IRS-1
/
and IRS-1
/
IRS-2
/
cells were comparable to those of wild-type
cells. Somewhat surprisingly, C/EBP
expression in
IRS-1
/
and IRS-1
/
IRS-2
/
cells was greater than that in wild-type cells.
By contrast, the expression of C/EBP
in IRS-1
/
IRS-2
/
cells was markedly reduced. The expression of
PPAR
was also severely decreased in IRS-1
/
IRS-2
/
cells. Although the expression of SREBP1c (ADD1)
was significantly reduced 4 and 8 days after induction in
IRS-1
/
IRS-2
/
cells, it caught up with
that of wild-type cells by 12 days after induction. The expression of
LPL and aP2 mRNAs was severely decreased but not abolished in
IRS-1
/
IRS-2
/
cells.
|
and C/EBP
in wild-type cells were
examined by Northern blotting. Expressions of both PPAR
and C/EBP
at 8 days after induction were severely decreased in wild-type cells
treated with 20 µM LY294002 (Fig. 5B).
Expression of PPAR
and C/EBP
was markedly reduced on the
protein level in IRS-1
/
IRS-2
/
cells.
Immunoblotting analysis was performed to assess the
expression of PPAR
and C/EBP
on the protein level. The expression
of C/EBP
was markedly reduced on the protein level in
IRS-1
/
IRS-2
/
cells at 8 days after
induction (Fig. 6A), and the PPAR
protein level in IRS-1
/
IRS-2
/
cells
was also markedly reduced (Fig. 6B). These results were consistent with
those obtained by Northern blotting analysis of the
IRS-1
/
IRS-2
/
cells.
|
Retroviral expression of PPAR
2 in IRS-1
/
IRS-2
/
cells partially rescued the lack of adipocyte
differentiation.
If the lack of PPAR
expression was responsible
for the observed lack of lipid accumulation in IRS-1
/
IRS-2
/
cells, it was thought that forced expression of
PPAR
might rescue adipocyte differentiation. To determine whether it
would, we performed retrovirus-mediated PPAR
gene transfer into
IRS-1
/
IRS-2
/
cells. The results of
Oil-Red O staining showed that forced expression of PPAR
2 in
IRS-1
/
cells completely rescued the impaired adipocyte
differentiation. Forced expression of PPAR
2 in
IRS-1
/
IRS-2
/
cells, however, rescued
it only in part, not to the same level as in mock-vector-transferred
wild-type cells (Fig. 7), suggesting that
IRS-1 and IRS-2 are required for full adipocyte differentiation in
addition to their roles to induce PPAR
2.
|
WAT mass of IRS-1
/
IRS-2
/
double-knockout mice was markedly reduced.
To address whether the
in vitro effects observed in this study are translated into effects on
adiposity in vivo, we tried to produce IRS-1
/
IRS-2
/
double-knockout mice. Interestingly, they were
carried to term (R. Suzuki et al., unpublished data). Because white
adipose tissue (WAT) appears at birth during mouse development, mice at
the 8-h postnatal point were examined histologically (Fig.
8). At 8 h after birth, control
animals had abundant subcutaneous WAT. In contrast, WAT mass was
dramatically reduced, but not abrogated, in the newborn
IRS-1
/
IRS-2
/
double-knockout mice.
Surprisingly, brown adipose tissue (BAT) mass in IRS-1
/
IRS-2
/
double-knockout mice was almost the same as that
in control mice.
|
| |
DISCUSSION |
|---|
|
|
|---|
Adipocyte differentiation is an important aspect of energy
balance. Although cascades and networks of transcriptional factors during adipocyte differentiation have been investigated rather thoroughly, the signaling mechanism by extracellular hormones and
growth factors regulating the cascades and networks of adipose-specific transcriptional factors remains unclear (30). Insulin and
IGF-1 have been reported to play important roles in adipocyte
differentiation (5, 13, 14). In this study, we
investigated the role of IRS-1 and IRS-2, the two major common
substrates for insulin and IGF-1 receptor tyrosine kinases, in
adipocyte differentiation. Using a gene ablation strategy, we found
that the abilities of IRS-1
/
cells and
IRS-2
/
cells to differentiate into adipocytes were
reduced by 60 and 15%, respectively, compared to that of wild-type
cells. These results indicate that even though both IRS-1 and IRS-2 are
required for full capacity of adipocyte differentiation, IRS-1 plays a more role in adipocyte differentiation. Moreover, it is possible that
IRS-2 and IRS-1 may have rescued the phenotype of
IRS-1
/
and IRS-2
/
cells, respectively,
in adipocyte differentiation. Therefore, to fully understand the role
of IRS-1 and IRS-2 in adipocyte differentiation, we established IRS-1
IRS-2 double-deficient EF cells. Our results clearly show that
IRS-1
/
IRS-2
/
cells have no ability to
differentiate into adipocytes; providing the first direct evidence that
IRS-1 and IRS-2 are absolutely essential to adipocyte differentiation.
Since IRS-1 and IRS-2 are important mediators of insulin and IGF-1 actions, these data may imply that the absence of IRS-1 and IRS-2 impairs hormonal activation of adipogenesis. It should be noted, however, that this study does not address which tyrosine kinase(s) phosphorylate IRS-1 and IRS-2 during adipocyte differentiation. Therefore, it is possible that tyrosine phosphorylation of IRS-1 and IRS-2 by putative upstream tyrosine kinase(s) other than insulin and IGF-1 receptor tyrosine kinases plays a crucial role in in vitro adipocyte differentiation or in vivo adipogenesis. Data from Chaika et al. (6) suggest that the insulin receptor tyrosine kinase was still capable of stimulating adipocyte differentiation even when mutated such that it could no longer phosphorylate IRS proteins.
The present study strongly suggests the important role of tyrosine-phosphorylated IRS-1 and IRS-2 and PI 3-kinase activation by three lines of experimental results: (i) adipocyte differentiation capacity parallels PI 3-kinase activity, which increases during adipocyte differentiation, among the four genotypes; (ii) PI 3-kinase inhibitor completely blocks adipocyte differentiation; and (iii) phosphorylation of MAP kinase is unaltered in any of the four genotypes. Consistent with our results, several studies (31, 40, 47, 54) have reported that PI 3-kinase activity plays a role in adipocyte differentiation by using dominant-negative p85, wortmannin, or LY294002, inhibitors of PI 3-kinase. Moreover, Kohn et al. and Magun et al. have demonstrated the role of activation of PI 3-kinase and one of its downstream mediators, Akt, to induce adipocyte differentiation by constitutive active form of Akt Ser/Thr kinase (20, 24). Taken together with these reports, the present study strongly suggests that PI 3-kinase activity activated through induction of tyrosine phosphorylation of IRS-1 and IRS-2 is essential to adipocyte differentiation.
To further clarify the mechanism by which IRS-1 and IRS-2 fulfill their
role in adipocyte differentiation, we investigated the expression of
transcriptional factors for adipocyte differentiation and adipogenic
markers. The results show that the mRNA expression of C/EBP
and
PPAR
is severely decreased in IRS-1
/
IRS-2
/
cells, although the expression of C/EBP
is
unaltered and the expression of C/EBP
is even slightly increased. It
therefore seems possible that IRS-1 and IRS-2 upregulate the expression of C/EBP
and PPAR
, but the molecular link between IRS-1, IRS-2, and PI 3-kinase and the upregulation of these transcription factors is
unclear and requires further investigation. The expression of LPL and
aP2, whose promoters have a PPAR response element (PPRE), is parallel
to the expression of PPAR
. Although the expression of SREBP1c is at
least in part dependent on the expression of PPAR
, as previously
reported (21), SREBP1c has been reported to be also
regulated by many other factors (11). At day 12 after induction the expression of SREBP1c in IRS-1
/
IRS-2
/
cells is induced to almost the same amount as
that in wild-type cells. It indicates that upstream signaling
pathway(s) other than IRS-1 and IRS-2 may be involved in the
regulation of the expression of SREBP1c. Nevertheless, normal
expression of SREBP1c at day 12 is not sufficient to induce adipocyte
differentiation in IRS-1
/
IRS-2
/
cells.
To further study the role of PI 3-kinase in adipocyte differentiation,
we examined whether inhibition of PI 3-kinase during adipocyte
differentiation affects the mRNA expressions of PPAR
and C/EBP
in
wild-type cells. As shown in Fig. 5B, mRNAs of both PPAR
and
C/EBP
decrease significantly in wild-type cells treated with 20 µM
LY294002. It strongly suggests that the inhibition of PI 3-kinase
blocks adipogenesis due to severe reduction in expression of both
PPAR
and C/EBP
mRNAs. Our present data appear to differ from
those of a previous report (31) that the inhibition of PI
3-kinase in 3T3-F442A cells by expressing dominant-negative p85 does
not affect the expression of the transcription factor PPAR
at the
mRNA level using insulin and 5,8,11,14-eicosatetraynoic acid (ETYA) as
inducers for adipocyte differentiation (31). The reasons
for the apparent discrepancy between our data and those of Sakaue et
al. (31) are unknown at present but could be related to
differences in methods such as cell type (primary EF cells versus
3T3-F442A) or inducers for differentiation (IBMX, DEX, and insulin
versus ETYA and insulin) or means to inhibit PI 3-kinase (LY294002
versus dominant-negative p85). On the other hand, our present result
that PI 3-kinase inhibition using LY294002 decreases PPAR
mRNA is
consistent with the study by Xia and Serrero (54), in
which they demonstrated treatment of 3T3-L1 adipocytes with LY294002
inhibited PPAR
expression and adipocyte differentiation induced by
IBMX, DEX, and insulin. Identification of signals downstream of IRS-1
and IRS-2 mediating the upregulation of PPAR
and C/EBP
mRNA
expression is an important subject of future research.
Restoration of PPAR
to IRS-1
/
IRS-2
/
cells by retrovirus-mediated gene transfer partially rescues the
defective adipocyte differentiation. This is consistent with the
hypothesis that one of the roles of IRS-1 and IRS-2 in adipocyte
differentiation is upregulation of mRNA expression of PPAR
. On the
other hand, the fact that PPAR
is unable to completely rescue the
defective adipocyte differentiation suggests that IRS-1 and IRS-2 may
stimulate adipocyte differentiation via distinct mechanism(s) in
addition to induction of PPAR
.
Histological analyses of IRS-1
/
IRS-2
/
double-knockout mice show severe reduction in WAT but not in BAT. These
data may provide the evidence that the essential role of IRS-1 and
IRS-2 in adipocyte differentiation in vitro can be extended to that in
development of WAT in vivo. It should be noted, however, that WAT mass
is not completely abrogated in IRS-1
/
IRS-2
/
double-knockout mice. These differences in
adipogenesis between in vitro and in vivo have been previously observed
in the report of Tanaka et al. on C/EBP
and C/EBP
knockout mice
(39). In in vitro differentiation experiments, the only
differentiation stimuli are MIX, DEX, INS and FBS; however, in vivo,
there are many other adipogenic factors such as growth hormone, IGF-1,
and prostaglandins. With the restricted number of stimuli in vitro, IRS-1 and IRS-2 is absolutely required for the expression of PPAR
and C/EBP
and for adipocyte differentiation. However, the lack of
adipogenesis may be partially rescued with additional stimuli in vivo
which are not absolutely dependent upon the presence of IRS-1 and
IRS-2.
In conclusion, this study is the first to report that IRS-1 and IRS-2
play an essential role in adipocyte differentiation and adipogenesis.
Moreover, we propose that IRS-1 and IRS-2 play crucial roles in
adipocyte differentiation through the upregulation of mRNA expression
of PPAR
and C/EBP
subsequent to induction of C/EBP
and
C/EBP
(Fig. 9).
|
| |
ACKNOWLEDGMENTS |
|---|
We thank B. M. Spiegelman and N. Yahagi for providing PPAR
2
expression vector and 36B4 cDNA probe, respectively, and E. Yoshida-Nagata and H. Chiyonobu for excellent technical assistance.
This work was supported by a grant-in-aid for creative basic research (10NP0201) from the Ministry of Education, Science, Sports, and Culture of Japan (to T. Kadowaki) and by health science research grants (Research on Human Genome and Gene Therapy) from the Ministry of Health and Welfare (to T. Kadowaki).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Internal Medicine, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. Phone: 81-3-5800-8818. Fax: 81-3-5689-7209. E-mail: kadowaki-3im{at}h.u-tokyo.ac.jp.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Akira, S., H. Isshiki, T. Sugita, O. Tanabe, S. Kinoshita, Y. Nishio, T. Nakajima, T. Hirano, and T. Kishimoto. 1990. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 9:1897-1906[Medline]. |
| 2. |
Altiok, S.,
M. Xu, and B. M. Spiegelman.
1997.
PPAR induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A.
Genes Dev.
11:1987-1998 |
| 3. | Bruning, J. C., J. Winnay, B. Cheatham, and C. R. Kahn. 1997. Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells. Mol. Cell. Biol. 17:1513-1521[Abstract]. |
| 4. |
Cao, Z.,
R. M. Umek, and S. L. McKnight.
1991.
Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells.
Genes Dev.
5:1538-1552 |
| 5. | Catalioto, R. M., D. Gailard, G. Ailhaud, and R. Negrel. 1992. Terminal differentiation of mouse preadipocyte cells: the mitogenic-adipogenic role of growth hormone is mediated by the protein kinase C signalling pathway. Growth Factors 6:255-264[Medline]. |
| 6. |
Chaika, O. V.,
N. Chaika,
D. J. Volle,
P. A. Wilden,
S. J. Pirrucello, and R. E. Lewis.
1997.
CSF-1 receptor/insulin receptor chimera permits CSF-1-dependent differentiation of 3T3-L1 preadipocytes.
J. Biol. Chem.
272:11968-11974 |
| 7. |
Chang, C. J.,
T. T. Chen,
H. Y. Lei,
D. S. Chen, and S. C. Lee.
1990.
Molecular cloning of a transcription factor, AGP/EBP, that belongs to members of the C/EBP family.
Mol. Cell. Biol.
10:6642-6653 |
| 8. |
Christy, R. J.,
K. H. Kaestner,
D. E. Geiman, and M. D. Lane.
1991.
CCAAT/enhancer binding protein gene promoter: binding of nuclear factors during differentiation of 3T3-L1 preadipocytes.
Proc. Natl. Acad. Sci. USA
88:2593-2597 |
| 9. |
Christy, R. J.,
V. W. Yang,
J. M. Ntambi,
D. E. Geiman,
W. H. Landschulz,
A. D. Friedman,
Y. Nakabeppu,
T. J. Kelly, and M. D. Lane.
1989.
Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes.
Genes Dev.
3:1323-1335 |
| 10. |
Descombes, P.,
M. Chojkier,
S. Lichtsteiner,
E. Falvey, and U. Schibler.
1990.
LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein.
Genes Dev.
4:1541-1551 |
| 11. |
Foretz, M.,
C. Pacot,
I. Dugail,
P. Lemarchand,
C. Guichard,
X. Le Liepvre,
C. Berthelier-Lubrano,
B. Spiegelman,
J. B. Kim,
P. Ferre, and F. Foufelle.
1999.
ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose.
Mol. Cell. Biol.
19:3760-3768 |
| 12. |
Freytag, S. O.,
D. L. Paielli, and J. D. Gilbert.
1994.
Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells.
Genes Dev.
8:1654-1663 |
| 13. | Green, H., M. Morikawa, and T. Nixon. 1985. A dual effector theory of growth-hormone action. Differentiation 29:195-198[CrossRef][Medline]. |
| 14. | Guller, S., R. E. Corin, K. Yuan-Wu, and M. Sonenberg. 1991. Up-regulation of vinculin expression in 3T3 preadipose cells by growth hormone. Endocrinology 129:527-533[Abstract]. |
| 15. |
Hu, E.,
P. Tontonoz, and B. M. Spiegelman.
1995.
Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha.
Proc. Natl. Acad. Sci. USA
92:9856-9860 |
| 16. |
Kageyama, R.,
Y. Sasai, and S. Nakanishi.
1991.
Molecular characterization of transcription factors that bind to the cAMP responsive region of the substance P precursor gene. cDNA cloning of a novel C/EBP-related factor.
J. Biol. Chem.
266:15525-15531 |
| 17. |
Kim, J. B., and B. M. Spiegelman.
1996.
ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism.
Genes Dev.
10:1096-1107 |
| 18. | Kim, J. B., H. M. Wright, M. Wright, an |